StockData

Spyre Therapeutics, Inc. (SYRE) stock

SYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$97.63−3.83 (-3.77%)

Close on Nov 19, 2026Market cap $8.61BP/E –Yield –

Spyre Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Spyre Therapeutics's market cap was $9.41B on Nov 11, 2026, against $1.81B a year earlier. Over the last 5 years it ranged from $8.49M to $9.41B, with a median of $972.25M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.41B+374.8%
2025Dec 31, 2025$1.98B+65.6%
2024Dec 31, 2024$1.20B+1273.3%
2023Dec 29, 2023$87.13M+214.8%
2022Dec 30, 2022$27.67M-88.2%
2021Dec 31, 2021$234.20M-33.4%
2020Dec 31, 2020$351.73M+59.2%
2019Dec 31, 2019$220.97M+33.5%
2018Dec 31, 2018$165.52M+85.7%
2017Dec 29, 2017$89.12M+52.5%
2016Dec 30, 2016$58.42M–

More Spyre Therapeutics figures

See a number that looks wrong?